Delivery Order SPE2DR25D2001-SPE2DR26FBFZ7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xcopri 100 mg tablets (30-count units) under a firm fixed-price contract valued at $1,712.07. This non-set-aside award was issued on November 25, 2025, with an ultimate completion date of November 26, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location in the same city. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xcopri 50 mg tablets (30-count units) valued at $2,301.29 under a firm fixed-price contract. The award was made on December 15, 2025, with an ultimate completion date of December 16, 2025, and represents a non-competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,687.09 to supply Xcopri 150 mg tablets (30-count) with a firm fixed price contract structure. This non-competitive set-aside delivery order, issued on December 10, 2025, represents a child contract under a larger vehicle and is scheduled for completion by December 11, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $1,251.04 delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Xcopri 100 mg tablets (30-count package). This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 12, 2025, and represents a child delivery order under AmerisourceBergen's larger prime contract vehicle with DLA. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Xcopri 200 mg tablets (30-count) with a ceiling value of $1,638.81. This is a firm fixed-price delivery order with an ultimate completion date of December 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,373.18 on December 9, 2025, for the supply of Xcopri 100 mg tablets (30-count units). This firm fixed-price delivery order, with an ultimate completion date of December 10, 2025, represents a non-competitive set-aside contract fulfilling pharmaceutical supply needs for the federal government. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Xcopri 100 mg tablets (30 count) with a ceiling value of $1,748.93. This firm fixed-price delivery order, which is not set-aside, is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Xcopri 100 mg tablets (30-count packaging) with a ceiling value of $1,178.96. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The order will be fulfilled from the...
- The Defense Logistics Agency awarded a delivery order valued at $1,768.44 to AmerisourceBergen Drug Corp for the supply of Xcopri 200 mg tablets (30-count units). This contract was competitively awarded on July 23, 2025, with a firm fixed price structure and an ultimate completion date of July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, reflecting open competition among...
- The Defense Logistics Agency awarded a $1,227.16 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Xcopri 150 mg tablets (30-count units). This firm fixed-price, non-set-aside contract is classified as a child award under a larger indefinite delivery contract vehicle and represents a routine pharmaceutical procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with...
- SPE2DR25D2001Indefinite Delivery Contract
- SPE2DR25D2001-SPE2DR26FBFZ7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xcopri 150 mg tablets (30-count) valued at $1,688.86 under a firm fixed-price contract. This non-set-aside award was issued on December 16, 2025, with an ultimate completion date of December 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a $999,999,999.00 ceiling value and extends through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to fulfill competitive federal medical supply requirements across multiple therapeutic domains through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/15/25 |